Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 43.1840
Recommendation STRONG BUY
P/E 2.50
ROE 23.54 %
Capitalization 429,723,550 $
Dividend Yield 0.00 %
P/S 2.17
AII Position 59
P/E Position 10
ROE Position 125
Capitalization Position 711
Dividend Yield Position 594
Sales 198,110,000 $
10-Year Average Earnings 171,765,600 $
Shares Outstanding 145,669,000
Equity 729,779,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2018 12 198,110,000.00 $
2017 12 320,060,000.00 $
2016 12 244,301,000.00 $
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -68,859,000.00 $
2017 12 110,748,000.00 $
2016 12 63,606,000.00 $
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 729,779,000.00 $
2017 12 845,890,000.00 $
2016 12 755,423,000.00 $
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 145,669,000
2017 12 156,257,000
2016 12 164,192,000
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:



Google News for PDL BIOPHARMA:

FinanceRecorder - 39 minutes ago
PDL BioPharma, Inc. (PDLI) Analysts See $0.04 EPS
Investors sentiment increased to 1.08 in Q1 2019. Its up 0.27, from 0.81 in 2018Q4. It increased, as 17 investors sold PDL BioPharma, Inc.
Valliant News
Reviewing PDL BioPharma Inc. (PDLI)'s and Jazz Pharmaceuticals ...
We will be contrasting the differences between PDL BioPharma Inc. (NASDAQ:PDLI) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ) as far as ...
Trent Times
Contrasting of PDL BioPharma Inc. (PDLI) and Arcturus ...
PDL BioPharma Inc. (NASDAQ:PDLI) and Arcturus Therapeutics Ltd. (NASDAQ:ARCT) have been rivals in the Biotechnology for quite some ...
Mayfield Recorder
PDL BioPharma (NASDAQ:PDLI) Share Price Passes Above Fifty ...
PDL BioPharma Inc (NASDAQ:PDLI) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving ...
The InvestReporter - 1 hour ago
Notable Trader's Round Up: Pdl Biopharma Inc ,(NASDAQ: PDLI)
On Wednesday the shares-rate of the Company Pdl Biopharma Inc, PDLI Stock exchange NASDAQ, is an exciting player in the Medical.
The MAK Daily
Magic Formula Rank For PDL BioPharma, Inc. ($PDLI$) Placed ...
The MF Rank of PDL BioPharma, Inc. (PDLI) is 99999. A company with a low rank is considered a good firm to invest in. The Magic Formula ...
The InvestReporter - 16 hours ago
Reviewing PDL BioPharma Inc. (PDLI)'s and Omeros Corporation ...
PDL BioPharma Inc. (NASDAQ:PDLI) and Omeros Corporation (NASDAQ:OMER) compete against each other in the Biotechnology sector.
Trent Times - 14 hours ago
PDL BioPharma Inc. (PDLI)'s Financial Results Comparing With ...
As Biotechnology businesses, PDL BioPharma Inc. (NASDAQ:PDLI) and Biofrontera AG (NASDAQ:BFRA), are affected by compare.
NyseNewsAnalyst (press release) - 1 day ago
Notable Stocks to Watch: Pdl Biopharma Inc ,(NASDAQ: PDLI)
On Tuesday the shares-rate of the Company Pdl Biopharma Inc, PDLI Stock exchange NASDAQ, is an exciting player in the Medical.
Addison Gazette
ArQule Inc. (ARQL) and PDL BioPharma Inc. (NASDAQ:PDLI ...
Both ArQule Inc. (NASDAQ:ARQL) and PDL BioPharma Inc. (NASDAQ:PDLI) are Biotechnology companies, competing one another. We will ...


Back